Norfloxacin Lactate Injection CAS 97867-34-0
| CAS No. | 97867-34-0 |
| Molecular Formula | C16H18FN3O3 |
| Molecular Weight | N/A |
| Category | Pharmaceutical Standards / API Standards |
| Availability | In Stock |
Chemical Structure
Description
The occurrence of Norfloxacin Lactate Injection is closely related to a flavonoid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution in its molecular formula, which determines its behaviour during synthesis, purification, or degradation.
Norfloxacin Lactate Injection (CAS 97867-34-0), molecular formula C16H18FN3O3C3H6O3 and molecular weight 409.41 g/mol, is a CATO reference standard with documented purity and traceability.
Structurally, Norfloxacin Lactate Injection (C16H18FN3O3C3H6O3) contains a flavonoid core, an amide group, a hydroxyl group, an ether linkage, fluorine substitution. The molecule exhibits a degree of unsaturation (DBE) of 9.0, corresponding to approximately 9 ring(s) or double-bond equivalent(s). With a molecular weight of 409.41 g/mol, it falls into the moderately-high-molecular-weight range. The presence of an aromatic ring or conjugated system gives the compound characteristic absorption bands in the UV-Vis region, making it well suited to UV or diode-array detection (DAD).
Recommended for analytical method development and validation; each product is supplied with a full Certificate of Analysis (COA) ensuring ISO 17034 metrological traceability.
The assigned purity is verified by mass-balance and quantitative NMR (qNMR) approaches, with the expanded uncertainty reported at a 95% confidence level (k=2). Batch homogeneity and stability are independently assessed for every lot.
Physical & Chemical Properties
| Molecular Formula | C16H18FN3O3 C3H6O3 |
| Molecular Weight | 409.41 g/mol |
| Appearance | Pale yellow to yellow crystalline powder. (slight halide-like odor) |
| Purity | >95% |
| Storage | Store in a cool place (≤25°C), protect from light, keep sealed and dry |
| Solubility (reference) | Soluble in DMSO, DMF, methanol |
| Stability | May oxidize slowly on prolonged air exposure; Light-sensitive; avoid direct strong light; Hygroscopic; reseal immediately after opening; Contains ester bond; hydrolyzes under strong alkaline conditions |
| Degree of Unsaturation (DBE) | 9.0 |
| UV Absorption | UV-absorbing |
| Structural Features | Aromatic ring present |
| CAS Registry Year (est.) | 1984 |
| Halogen Content | F-containing |
| Nitrogen Atoms | 3 |
Related Norfloxacin Standards
- Norfloxacin-D5 (CAS 1015856-57-1)
- Norfloxacin Impurity 21 (CAS 103240-27-3)
- Norfloxacin Hydrochloride (CAS 104142-93-0)
- Norfloxacin EP Impurity H (CAS 105440-01-5)
- Norfloxacin Impurity C70 (CAS 106847-38-5)
- Norfloxacin Impurity C171 (CAS 106847-39-6)
- Norfloxacin Impurity 63 (CAS 106847-42-1)
- Norfloxacin Impurity 22 (CAS 109142-49-6)
Recommended Standards
- rel-(3S,3aS,6aR)-2-tert-butoxycarbonyl-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-3-carboxylic acid (CAS 926276-09-7)
- 2-(2-bromo-4-pyridyl)propan-2-amine (CAS 1220127-22-9)
- 2,2’-Diiodobiphenyl-4,4’-diamine (CAS 54391-31-0)
- Ethyl 2-(cyclopropanecarboxamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxylate (CAS 312528-58-8)
- [1-(2,2,2-Trifluoroethyl)cyclobutyl]methanamine (CAS 1849283-85-7)
- 3-Bromo-4-((tetrahydro-2H-pyran-4-yl)methoxy)benzaldehyde (CAS 1409894-40-1)
- 4-Phenyloxolan-2-one (CAS 1008-73-7)
- 7-Chloro-2-(pyridin-4-yl)indoline (CAS 591758-88-2)
- (Acetylcyclopentadienyl)cyclopentadienyl ruthenium (CAS 1316-92-3)
- Semaglutide impurity 96 (CAS CATO-C4X-222696)
Why CATO?
- ISO 17034 accredited reference material producer (CNAS + ANAB dual accreditation)
- 130,000+ catalog items in stock, COA supplied with every batch
- Worldwide shipping with full export documentation (HS code guidance available)
- Technical support: +86 18665070610 / Nicole.chen@cato-chem.com